Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma.
Authors:
- Y DengYDY Deng
- T WendtTWT Wendt
- B LiliensiekBLB Liliensiek
- A BierhausABA Bierhaus
- J GretenJGJ Greten
- W HeWHW He
- B ChenBCB Chen
- V Hach-WunderleVHV Hach-Wunderle
- R WaldherrRWR Waldherr
- R ZieglerRZR Ziegler
- D MännelDMD Männel
Open Access
- 15 May 1996
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 97 (10) , 2213-2224
Abstract
Fibrin is deposited on the endothelial cell surface in the vasculature of murine methylcholanthrene A-induced sarcomas after injection of tumor necrosis factor (TNF). Capillary endothelial cells of the tumor vascular bed become positive for tissue factor after TNF injection, based on immunocytochemistry and in situ hybridization. Intravascular clot formation was not dependent on tissue factor derived from tumor cells, since in vessels of tumors not expressing tissue factor, TNF also induced fibrin/fibrinogen deposition. However, the time course of fibrin/fibrinogen deposition after TNF differed in tumors expressing no, little, or greater amounts of tissue factor. Fibrin/fibrinogen deposition was more rapid in tumors in which the neoplastic cells expressed tissue factor than in tumors not expressing tissue factor. In the tumors not expressing tissue factor, activation of coagulation was dependent on TNF-induced synthesis of tissue factor by host cells, i.e., endothelium or monocytes/macrophages. Intravenous somatic gene transfer with tissue factor cDNA in the antisense orientation (but not sense or vector alone) reduced intravascular fibrin/fibrinogen deposition and restored blood flow to the tumor, showing that de novo tissue factor expression is central in TNF-induced activation of the coagulation mechanism.Keywords
This publication has 41 references indexed in Scilit:
- Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms.Journal of Biological Chemistry, 1992
- Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.Proceedings of the National Academy of Sciences, 1991
- Intrasplenic immunization with minute amounts of antigenImmunology Today, 1990
- Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.Journal of Experimental Medicine, 1990
- Initiation of Coagulation by Tissue FactoCritical Reviews in Biochemistry, 1988
- A universal retroviral vector for efficient constitutive expression of exogenous genesNucleic Acids Research, 1987
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.Journal of Experimental Medicine, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Actin gene expression visualized in chicken muscle tissue culture by using in situ hybridization with a biotinated nucleotide analog.Proceedings of the National Academy of Sciences, 1982
- Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences, 1980